Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2018
At a glance
- Drugs Caffeine citrate (Primary) ; Ibuprofen (Primary) ; Ketorolac (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- Acronyms SPIPROP study
- 31 Aug 2018 Biomarkers information updated
- 20 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Sep 2018.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.